Annovis BioFRA:07X -4.06%38 FCF Yield % is -36.26 as of Jun. 29, 2026. GuruFocus rates FRA:07X with a GF Score™ of 38/100. The stock has 1 warning sign investors should review. Among 1,415 Biotechnology companies, Annovis Bio ranks worse than 78.73% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Annovis Bio FCF Yield % Related Terms
Annovis Bio FCF Yield % Historical Data
* Premium members only.
The historical data trend for Annovis Bio's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:07X vs HYFT, EXOZ, ACRV: FCF Yield % Comparison
For the Biotechnology subindustry, Annovis Bio's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Annovis Bio FCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Annovis Bio's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Annovis Bio's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Annovis Bio (FRA:07X) has a FCF Yield % of -36.26 as of Jun. 29, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Annovis Bio and its competitors. According to the industry distribution chart, Annovis Bio ranks #1114 out of 1415 companies in the Biotechnology industry, placing it in the top 78.7%.
Is Annovis Bio's FCF Yield % too high?
Annovis Bio's current FCF Yield % is -36.26. Based on the distribution chart, Annovis Bio ranks #1114 out of 1415 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Annovis Bio has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Annovis Bio's FCF Yield % compare to HYFT and EXOZ?
According to the Biotechnology industry distribution chart, Annovis Bio ranks #1114 out of 1415 companies for FCF Yield %. This places Annovis Bio in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Annovis Bio and its competitors. Annovis Bio's current FCF Yield % is -36.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Annovis Bio stock overvalued right now?
Annovis Bio (FRA:07X) has a current FCF Yield % of -36.26. The current FCF Yield % is -36.26. Annovis Bio's overall GF Score™ is 38/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Annovis Bio (FRA:07X), the current FCF Yield % is -36.26 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.
38GF Score
Get the complete analysis for FRA:07X
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:07X has been successfully added to your 
